March 6, 2012 — In a development that brings advanced combination therapy treatment of peripheral artery disease (PAD) t ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
March 1, 2012 – Steris Corp. announced they will collaborate with device manufacturer St. Jude Medical Inc. on the ...
February 29, 2012 — Vessix Vascular Inc. announced initial patient treatments in the international multicenter Reduce ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
February 28, 2012 — Janssen Research and Development LLC announced that the U.S. Food and Drug Administration (FDA) has ...
February 28, 2012 — AccessClosure Inc. announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of ...
Avinger Inc. announced the enrollment of the first European patient in the CONNECT II global clinical trial. The first ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
February 24, 2012 — 3-D Surgical Solutions LLC and Wheaton Franciscan-The Wisconsin Heart Hospital Campus announced that ...
February 24, 2012 — A new report released today by HealthGrades found that from 2008 to 2010, emergency admissions for ...
February 24, 2012 – The U.S. Food and Drug Administration (FDA) this week granted the first coronary stent indication ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
February 20, 2012 — ReCor Medical announced that its Paradise percutaneous ultrasound renal denervation system for ...
February 20, 2012 — Medtronic announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity drug ...
As catheter-based, minimally invasive procedures expand rapidly beyond treatment of the coronary arteries into all areas ...
During cardiology fellowship, my institution had a hand manifold system. I found it difficult to use at times, and it ...
February 16, 2012 — Siemens Healthcare received clearance from the U.S. Food and Drug Administration (FDA) for syngo Aor ...
February 16, 2012 — Velomedix Inc., a clinical stage medical device company, received investigational device exemption ...
February 15, 2012 — Vessix Vascular Inc., developer of a novel percutaneous radiofrequency (RF) balloon catheter ...